AIML Announces Engagement of Guerilla Capital for Communications and Investor Outreach Efforts
AI/ML Innovations (OTC:AIMLF) has engaged Guerilla Capital to provide investor relations, communications, and investor outreach services.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AI/ML Innovations (OTC:AIMLF) has engaged Guerilla Capital to provide investor relations, communications, and investor outreach services.
The engagement starts immediately for an initial term of 12 months at an aggregate fee of Cdn$120,000. Cdn$30,000 is payable up front and the remaining Cdn$90,000 is payable in three quarterly installments of Cdn$30,000. The agreement may be terminated any time after the initial three months.
Details
News Market Reaction – AIMLF
On Dec 11, the day this news came out, AIMLF closed 4.51% below the previous close.
Data tracked by StockTitan Argus for the Dec 11 session.
Key Figures
- IR contract value
- Cdn$120,000
- Aggregate fee for 12‑month Guerilla Capital engagement
- Upfront payment
- Cdn$30,000
- Initial payment at start of Guerilla Capital engagement
- Quarterly installments
- Cdn$30,000
- Paid quarterly over remaining term of 12‑month engagement
- Engagement term
- 12 months
- Initial duration of investor relations services contract
Historical Context
-
Non-binding term sheet to integrate MaxYield and Insight360 into wellness platform.
-
Pilot with Cornerstone Physiotherapy for elite athlete cardiac performance testing.
-
Equimetrics term sheet to deploy MaxYield and CardioYield across equine platforms.
-
U.S. patent allowance protecting core ECG signal-processing architecture.
-
Engagement of consultants for CardioYield submission in Jamaica plus stock option grant.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TORONTO, ON / ACCESS Newswire / December 11, 2025 / AI/ML Innovations Inc. (CSE:AIML) ("AIML" or the "Company") is pleased to announce the engagement of Guerilla Capital ("Guerilla"), an arm's length investor relations firm with offices in Ontario, Canada. Guerilla will provide investor relations services to the Company including enhancing the Company's communications and investor outreach efforts.
The initial term of the engagement will commence immediately and continue for a period of 12 months (subject to extension) at an aggregate fee of Cdn
Guerilla may be contacted at:
2855322 ONTARIO INC. O/A GUERILLA CAPITAL
84 Watson' Lane, Dundas, Ontario, L9H 1T3
Email: Ryan@guerillacapital.io
Telephone: 416-832-1874
About AI/ML Innovations Inc.
AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment, and more effective care.
AIML's shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB).
For detailed information please see AIML's website or the Company's filed documents at www.sedarplus.ca.
Contact:
Blake Fallis (778) 405-0882
On behalf of the Board of Directors:
Paul Duffy, Executive Chairman and CEO
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements - Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, including risks associated with the implementation of the Company's products and services. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including with respect to the nature and timing of future operations and the receipt of all applicable regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.
SOURCE: AI/ML Innovations, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.